232 related articles for article (PubMed ID: 28818705)
41. The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.
van der Aa JE; Hoogendam JP; Butter ES; Ausems MG; Verheijen RH; Zweemer RP
Fam Cancer; 2015 Dec; 14(4):539-44. PubMed ID: 26264902
[TBL] [Abstract][Full Text] [Related]
42. Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy.
Teixeira N; Mourits MJ; Oosterwijk JC; Fakkert IE; Absalom AR; Bakker SJL; van der Meer P; de Bock GH
Fam Cancer; 2019 Jan; 18(1):19-27. PubMed ID: 29881922
[TBL] [Abstract][Full Text] [Related]
43. Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.
Robson M; Hensley M; Barakat R; Brown C; Chi D; Poynor E; Offit K
Gynecol Oncol; 2003 May; 89(2):281-7. PubMed ID: 12713992
[TBL] [Abstract][Full Text] [Related]
44. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
[TBL] [Abstract][Full Text] [Related]
45. Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis.
Lip GY; Blann AD; Jones AF; Beevers DG
Am Heart J; 1997 Oct; 134(4):764-71. PubMed ID: 9351746
[TBL] [Abstract][Full Text] [Related]
46. Hormone Therapy Use After Premature Surgical Menopause Based on Prescription Records: A Population-Based Study.
Jang JH; Arora N; Kwon JS; Hanley GE
J Obstet Gynaecol Can; 2020 Dec; 42(12):1511-1517. PubMed ID: 32723606
[TBL] [Abstract][Full Text] [Related]
47. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
[TBL] [Abstract][Full Text] [Related]
48. Review Article: Sexuality and Risk-Reducing Salpingo-oophorectomy.
Tucker PE; Cohen PA
Int J Gynecol Cancer; 2017 May; 27(4):847-852. PubMed ID: 28333842
[TBL] [Abstract][Full Text] [Related]
49. The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause.
Pezaro C; James P; McKinley J; Shanahan M; Young MA; Mitchell G
Fam Cancer; 2012 Sep; 11(3):403-10. PubMed ID: 22477030
[TBL] [Abstract][Full Text] [Related]
50. Safety of hormone replacement therapy in gynaecological cancer survivors.
Biliatis I; Thomakos N; Rodolakis A; Akrivos N; Zacharakis D; Antsaklis A
J Obstet Gynaecol; 2012 May; 32(4):321-5. PubMed ID: 22519472
[TBL] [Abstract][Full Text] [Related]
51. Effect of risk-reducing salpingo-oophorectomy on the quality of life in Korean BRCA mutation carriers.
Chae S; Kim EK; Jang YR; Lee AS; Kim SK; Suh DH; Kim K; No JH; Kim YB; Kim SW; Kang E
Asian J Surg; 2021 Aug; 44(8):1056-1062. PubMed ID: 33573923
[TBL] [Abstract][Full Text] [Related]
52. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
Finch A; Metcalfe KA; Chiang JK; Elit L; McLaughlin J; Springate C; Demsky R; Murphy J; Rosen B; Narod SA
Gynecol Oncol; 2011 Apr; 121(1):163-8. PubMed ID: 21216453
[TBL] [Abstract][Full Text] [Related]
53. Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer.
Fakkert IE; van der Veer E; Abma EM; Lefrandt JD; Wolffenbuttel BH; Oosterwijk JC; Slart RH; Westrik IG; de Bock GH; Mourits MJ
PLoS One; 2017; 12(1):e0169673. PubMed ID: 28060958
[TBL] [Abstract][Full Text] [Related]
54. Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.
Challberg J; Ashcroft L; Lalloo F; Eckersley B; Clayton R; Hopwood P; Selby P; Howell A; Evans DG
Br J Cancer; 2011 Jun; 105(1):22-7. PubMed ID: 21654687
[TBL] [Abstract][Full Text] [Related]
55. Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.
Palaia I; Caruso G; Di Donato V; Turetta C; Savarese A; Perniola G; Gallo R; Giannini A; Salutari V; Bogani G; Tomao F; Giannarelli D; Gentile G; Musella A; Muzii L; Pignata S;
J Gynecol Oncol; 2024 May; 35(3):e70. PubMed ID: 38497108
[TBL] [Abstract][Full Text] [Related]
56. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Madalinska JB; Hollenstein J; Bleiker E; van Beurden M; Valdimarsdottir HB; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2005 Oct; 23(28):6890-8. PubMed ID: 16129845
[TBL] [Abstract][Full Text] [Related]
57. Hormone replacement and menopausal symptoms following hysterectomy.
Langenberg P; Kjerulff KH; Stolley PD
Am J Epidemiol; 1997 Nov; 146(10):870-80. PubMed ID: 9384207
[TBL] [Abstract][Full Text] [Related]
58. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers.
Marchetti C; De Felice F; Palaia I; Perniola G; Musella A; Musio D; Muzii L; Tombolini V; Panici PB
BMC Womens Health; 2014 Dec; 14():150. PubMed ID: 25494812
[TBL] [Abstract][Full Text] [Related]
59. Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy.
DeLeo MJ; Domchek SM; Kontos D; Conant E; Chen J; Weinstein S
AJR Am J Roentgenol; 2015 Mar; 204(3):669-73. PubMed ID: 25714301
[TBL] [Abstract][Full Text] [Related]
60. Compliance with estrogen hormone replacement therapy after oophorectomy: a prospective study.
Read MD; Edey KA; Hapeshi J; Foy C
Menopause Int; 2010 Jun; 16(2):60-4. PubMed ID: 20729495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
